Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 668.18M | 641.44M | 639.78M | 668.92M | 672.77M |
| Total Depreciation and Amortization | 201.61M | 193.71M | 183.13M | 181.51M | 179.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.70M | -7.05M | 11.93M | -34.47M | -59.04M |
| Change in Net Operating Assets | -357.93M | -397.94M | -426.14M | -301.65M | -243.62M |
| Cash from Operations | 545.56M | 430.17M | 408.70M | 514.30M | 549.39M |
| Capital Expenditure | -324.94M | -299.57M | -260.46M | -215.05M | -198.09M |
| Sale of Property, Plant, and Equipment | 6.12M | 6.87M | 11.85M | 14.99M | 12.83M |
| Cash Acquisitions | -633.24M | -614.12M | -614.12M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 263.39M | 235.12M | 61.27M | -428.36M | -300.68M |
| Cash from Investing | -688.68M | -671.70M | -801.46M | -628.42M | -485.94M |
| Total Debt Issued | 24.49B | 29.76B | 33.05B | 16.06B | 9.29B |
| Total Debt Repaid | -1.29B | -1.31B | -304.00M | -456.00M | -4.95B |
| Issuance of Common Stock | 193.00M | 213.00M | 197.00M | 745.00M | 805.00M |
| Repurchase of Common Stock | -1.39B | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -79.53M | -79.53M | -79.53M | -80.41M | -80.41M |
| Other Financing Activities | 3.57B | 3.75B | 4.16B | -2.45B | -2.27B |
| Cash from Financing | 229.02M | 307.75M | 364.22M | 86.31M | -46.03M |
| Foreign Exchange rate Adjustments | 2.59M | -912.80K | 1.08M | 556.90K | -730.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.49M | 65.30M | -27.46M | -27.25M | 16.69M |